So I heard this on the street . . . Kindler's secret plan for Pfizer is not to get the stock up . . . that's virtually impossible, and he knows it.
Solution: Drive the stock down to below $14, enough to get the sharks circling, then accept a take-over offer for $22, and cash in all executive management parachutes.
You heard it here first.
